New leukemia treatment exceeds 'wildest expectations'
Doctors have treated only three leukemia patients, but the sensational results from a single shot could be one of the most significant advances in cancer research in decades. And it almost never happened. In the research published Wednesday, doctors at the University of Pennsylvania say the treatment made the most common type of leukemia completely disappear in two of the patients and reduced it by 70% in the third. In each of the patients as much as five pounds of cancerous tissue completely melted away in a few weeks, and a year later it is still gone. The results of the preliminary test "exceeded our wildest expectations," says immunologist Carl June, MD, a member of the Abramson Cancer Center's research team. Edgar Engleman, MD, a cancer immunologist at Stanford University School of Medicine who was not involved in the research calls the results "remarkable ... great stuff.
- 'Mega Boards' Could be Rural Healthcare Disruptor
- Physicians Trained in High-Cost Regions Spend More
- Narrow Networks Enjoying a Resurgence
- Ratcheting Up Patient Experience Has a Downside
- Christmas Tree Syndrome Season Underway
- HL20: Anne Wojcicki—Unlocking Consumer Access to Genetics
- Population Health Starts with Ending Hunger
- HL20: Tom X. Lee, MD—Reinventing Primary Care
- HL20: José Ramón Fernández-Peña, MD, MPA—A Welcoming Approach
- HL20: Steve Simonin—Turning It Around